|
Signing Ceremony for Joint Stem Cell Research Agreement with Seoul National University
2015.12.17
|
|---|
|
On December 15, 2015, Daehan New Pharm signed an agreement with Professor Hwa-Young Yoon of the College of Veterinary Medicine at Seoul National University to conduct joint research and provide technical consultation for the industrialization of stem cells for companion animals.
Going forward, both parties plan to develop stem cells that can be widely applied to intractable diseases such as spinal cord injuries, degenerative arthritis, autoimmune disorders, and chronic renal failure through innovations in stem cell culture technology and various clinical trials. The developed technology will first be applied in animal hospitals and later expanded to the development of stem cell therapies for human use.
In addition, Daehan New Pharm plans to enhance its stem cell technologies currently under development and ownership to accelerate market entry, while also discussing potential export opportunities with overseas buyers in rapidly growing companion animal markets such as China and Vietnam, where economic growth and rising income levels are fueling expansion. |


Home